|
70 Companies |
|
97 Products |
|
97 Products |
|
124 Mechanisms of Action |
|
1 Trial |
|
1962 News |
|
| «12...28293031323334353637383940» |
- || buprenorphine/naloxone sublingual film / Generic mfg.
New P3 trial: NTX-SBX: Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway (clinicaltrials.gov) - Oct 29, 2012
P3, N=220, Recruiting, Sponsor: University of Oslo
- Enrollment change: KINECIG: Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes (clinicaltrials.gov) - Oct 28, 2012
P=N/A, N=15, Completed, Sponsor: Universita degli Studi di Catania
N=20 --> 15
- Trial completion: KINECIG: Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes (clinicaltrials.gov) - Oct 28, 2012
P=N/A, N=15, Completed, Sponsor: Universita degli Studi di Catania
N=20 --> 15 Recruiting --> Completed
- | buprenorphine/naloxone sublingual film / Generic mfg.
Enrollment open: NTX-SBX: Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway (clinicaltrials.gov) - Oct 27, 2012
P3, N=220, Recruiting, Sponsor: University of Oslo
Recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: Behavior and Driving Safety Study II (clinicaltrials.gov) - Oct 26, 2012
P=N/A, N=100, Active, not recruiting, Sponsor: University of California, Davis
Not yet recruiting --> Recruiting Enrolling by invitation --> Active, not recruiting
- Enrollment closed: BADS: Behavior and Driving Safety Study (clinicaltrials.gov) - Oct 26, 2012
P=N/A, N=800, Active, not recruiting, Sponsor: University of California, Davis
Enrolling by invitation --> Active, not recruiting Enrolling by invitation --> Active, not recruiting
- Enrollment change: Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth (clinicaltrials.gov) - Oct 25, 2012
P=N/A, N=800, Recruiting, Sponsor: Masonic Cancer Center, University of Minnesota
Enrolling by invitation --> Active, not recruiting N=340 --> 800
- Chantix (varenicline) / Pfizer
Enrollment closed: Efficacy of Varenicline for Smokeless Tobacco Use in India (clinicaltrials.gov) - Oct 25, 2012
P2, N=237, Active, not recruiting, Sponsor: University of Pennsylvania
N=340 --> 800 Recruiting --> Active, not recruiting
- Enrollment change: Brain Imaging of Cocaine Craving in Recreational Cocaine Users (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=9, Completed, Sponsor: James J. Prisciandaro
Recruiting --> Active, not recruiting N=30 --> 9
- New P2 trial: STED-CD: D-Serine for Cocaine Dependence Pilot (clinicaltrials.gov) - Oct 24, 2012
P2, N=0, Withdrawn, Sponsor: Theresa Winhusen
- Trial completion: Brain Imaging of Cocaine Craving in Recreational Cocaine Users (clinicaltrials.gov) - Oct 24, 2012
P=N/A, N=9, Completed, Sponsor: James J. Prisciandaro
N=30 --> 9 Recruiting --> Completed
- | Chantix (varenicline) / Pfizer
New P4 trial, HEOR: Helping HAND2: Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers (clinicaltrials.gov) - Oct 23, 2012
P4, N=1350, Recruiting, Sponsor: Massachusetts General Hospital
- Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Trial termination: PRO-809: Study of Probuphine in Patients With Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=16, Terminated, Sponsor: Titan Pharmaceuticals
Recruiting --> Completed Suspended --> Terminated; This study was terminated for reasons not related to efficacy or safety
- Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Trial termination: PRO-810: A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=9, Terminated, Sponsor: Titan Pharmaceuticals
Suspended --> Terminated; This study was terminated for reasons not related to efficacy or safety Suspended --> Terminated; This study was terminated for reasons not related to efficacy or safety
- Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Enrollment change: PRO-809: Study of Probuphine in Patients With Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=16, Terminated, Sponsor: Titan Pharmaceuticals
Suspended --> Terminated; This study was terminated for reasons not related to efficacy or safety N=200 --> 16
- Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Enrollment change: PRO-810: A Bioavailability and Safety Study of Probuphine Versus Sublingual Buprenorphine in Patients With Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=9, Terminated, Sponsor: Titan Pharmaceuticals
N=200 --> 16 N=16 --> 9
- buprenorphine/naloxone sublingual film / Generic mfg., methadone / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Enrollment open: Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution (clinicaltrials.gov) - Oct 22, 2012
P1, N=40, Recruiting, Sponsor: Johns Hopkins University
N=16 --> 9 Not yet recruiting --> Recruiting
- | Biomarker, Trial completion: Genetic Differences in Limbic Activation Associated With Nicotine Withdrawal (clinicaltrials.gov) - Oct 22, 2012
P3, N=64, Completed, Sponsor: M.D. Anderson Cancer Center
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||||||| Sixmo (buprenorphine implant) / Knight Therap, Titan, Molteni Therap
Trial completion: PRO-807: Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence (clinicaltrials.gov) - Oct 22, 2012
P3, N=62, Completed, Sponsor: Titan Pharmaceuticals
Active, not recruiting --> Completed Suspended --> Completed
- oxytocin / Generic mfg.
Trial initiation date: Oxytocin in Cocaine Dependence (clinicaltrials.gov) - Oct 21, 2012
P=N/A, N=152, Recruiting, Sponsor: Medical University of South Carolina
Suspended --> Completed Initiation date: Jul 2012 --> Oct 2012
- succinyl norcocaine & cholera toxin B (TA-CD) / Celtic
Enrollment closed: Multisite Controlled Trial of Cocaine Vaccine (clinicaltrials.gov) - Oct 21, 2012
P2, N=300, Active, not recruiting, Sponsor: Baylor College of Medicine
Initiation date: Jul 2012 --> Oct 2012 Recruiting --> Active, not recruiting
- Trial completion: Acamprosate in Alcoholics With Comorbid Anxiety or Depression (clinicaltrials.gov) - Oct 21, 2012
P4, N=90, Completed, Sponsor: Medical University of South Carolina
Recruiting --> Active, not recruiting Recruiting --> Completed
- naltrexone / Generic mfg.
Trial completion: Naltrexone and Adrenergic Agents to Reduce Heroin Use in Heroin Addicts (clinicaltrials.gov) - Oct 21, 2012
P2, N=301, Completed, Sponsor: Baylor College of Medicine
Recruiting --> Completed Recruiting --> Completed
- | methadone / Generic mfg.
Enrollment change: RCT Comparing Methadone and Buprenorphine in Pregnant Women (clinicaltrials.gov) - Oct 18, 2012
P3, N=175, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
Recruiting --> Completed N=300 --> 175
- || baclofen / Generic mfg.
New P3 trial: BacALD: Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver Disease (clinicaltrials.gov) - Oct 18, 2012
P3, N=180, Recruiting, Sponsor: South West Sydney Local Health District
- | methadone / Generic mfg.
Trial completion: RCT Comparing Methadone and Buprenorphine in Pregnant Women (clinicaltrials.gov) - Oct 18, 2012
P3, N=175, Completed, Sponsor: National Institute on Drug Abuse (NIDA)
N=300 --> 175 Active, not recruiting --> Completed
- New P2 trial: Transcranial Direct Current Stimulation in a Smoking Cessation Trial (clinicaltrials.gov) - Oct 17, 2012
P2, N=66, Suspended, Sponsor: Centre for Addiction and Mental Health
- | morphine sulphate / Generic mfg.
New P2 trial: Comparison of Buprenorphine to Morphine in Treatment of Neonatal Abstinence Syndrome (NAS) (clinicaltrials.gov) - Oct 15, 2012
P2, N=64, Enrolling by invitation, Sponsor: Pediatrix Medical Group
- Chantix (varenicline) / Pfizer
Trial completion: NCIG 003: Varenicline for Alcohol Dependence (clinicaltrials.gov) - Oct 15, 2012
P2, N=200, Completed, Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: CTN-0044: Web-delivery of Evidence-based, Psychosocial Treatment for Substance Use Disorders (clinicaltrials.gov) - Oct 14, 2012
P3, N=507, Completed, Sponsor: New York State Psychiatric Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | nepicastat (APL-1401) / Asieris
New P2 trial: A Multi-Center Trial of Nepicastat for Cocaine Dependence (clinicaltrials.gov) - Oct 9, 2012
P2, N=180, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
- Viibryd (vilazodone) / AbbVie
Enrollment open: Vilazodone Treatment for Marijuana Dependence (clinicaltrials.gov) - Oct 7, 2012
P2, N=76, Recruiting, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Biomarker: Biomarkers for the Prognosis of Decompensated Alcoholic Liver Disease (clinicaltrials.gov) - Oct 3, 2012
P=N/A, N=100, Recruiting, Sponsor: University of Nottingham
- buprenorphine/naloxone sublingual film / Generic mfg., methadone / Generic mfg., buprenorphine sublingual tablets / Generic mfg.
Trial initiation date: Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution (clinicaltrials.gov) - Oct 1, 2012
P1, N=40, Recruiting, Sponsor: Johns Hopkins University
Not yet recruiting --> Recruiting Initiation date: Mar 2012 --> Oct 2012
- quetiapine / Generic mfg.
Enrollment open: QUEST: Quetiapine Pharmacotherapy for Cannabis Dependence (clinicaltrials.gov) - Oct 1, 2012
P2, N=150, Recruiting, Sponsor: New York State Psychiatric Institute
Initiation date: Mar 2012 --> Oct 2012 Not yet recruiting --> Recruiting
- | quetiapine / Generic mfg.
New P2 trial: QUEST: Quetiapine Pharmacotherapy for Cannabis Dependence (clinicaltrials.gov) - Sep 30, 2012
P2, N=150, Recruiting, Sponsor: New York State Psychiatric Institute
- methamphetamine / Generic mfg.
Trial completion: STD Risk Reduction for Heterosexual Methamphetamine Users (clinicaltrials.gov) - Sep 26, 2012
P=N/A, N=432, Completed, Sponsor: University of California, San Diego
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- Trial completion: rTMS: Changing Thought and Action in Tobacco Dependence With Transcranial Magnetic Stimulation (clinicaltrials.gov) - Sep 25, 2012
P=N/A, N=66, Completed, Sponsor: University of Arkansas
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Trial initiation date: Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (clinicaltrials.gov) - Sep 23, 2012
P2, N=100, Recruiting, Sponsor: San Francisco Department of Public Health
Active, not recruiting --> Completed Initiation date: Nov 2011 --> Sep 2012
- Vivitrol (naltrexone extended-release injectable suspension) / Alkermes
Enrollment open: Extended-Release Naltrexone to Treat Methamphetamine Dependence in Men Who Have Sex With Men (MSM) (clinicaltrials.gov) - Sep 23, 2012
P2, N=100, Recruiting, Sponsor: San Francisco Department of Public Health
Initiation date: Nov 2011 --> Sep 2012 Not yet recruiting --> Recruiting
- galantamine extended release / Generic mfg.
Enrollment open: Effect of Galantamine on Short-term Abstinence (clinicaltrials.gov) - Sep 17, 2012
P2, N=80, Recruiting, Sponsor: University of Pennsylvania
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- pregnenolone / Duke University Health System
Enrollment change: The Effects of One-Time Pregnenolone, Dehydroepiandrosterone (DHEA), or Placebo Administration On Withdrawal Symptoms, Mood, Craving And Cigarette Evaluation Ratings In Male Smokers (clinicaltrials.gov) - Sep 13, 2012
P2, N=22, Completed, Sponsor: Jed E. Rose
Not yet recruiting --> Recruiting N=18 --> 22
- | Enrollment open: The Effectiveness of rTMS in Depressed VA Patients (clinicaltrials.gov) - Sep 13, 2012
P3, N=360, Recruiting, Sponsor: Department of Veterans Affairs
N=18 --> 22 Not yet recruiting --> Recruiting
- Trial completion: Study of the Effects of Motivational Enhancement Therapy on Alcohol Use in Chronic Hepatitis C Patients (clinicaltrials.gov) - Sep 13, 2012
P=N/A, N=136, Completed, Sponsor: Department of Veterans Affairs
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- naltrexone / Generic mfg.
Trial completion: SweetNal: Sweet Preference and Alcohol Craving (clinicaltrials.gov) - Sep 12, 2012
P2, N=80, Completed, Sponsor: University of North Carolina, Chapel Hill
Active, not recruiting --> Completed Recruiting --> Completed
- Trial completion: Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment (clinicaltrials.gov) - Sep 11, 2012
P1, N=46, Completed, Sponsor: University of Washington
Recruiting --> Completed Active, not recruiting --> Completed
- propranolol / Generic mfg.
Trial completion: Neuromodulation of Trauma Memories in PTSD & Alcohol Dependence (clinicaltrials.gov) - Sep 9, 2012
P2, N=44, Completed, Sponsor: Medical University of South Carolina
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment open: RAFIKI: A Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya Intervention (clinicaltrials.gov) - Sep 6, 2012
P1, N=336, Recruiting, Sponsor: Brown University
Recruiting --> Completed Not yet recruiting --> Recruiting
- Clinical: Understanding Drug Abuse Treatment Outcomes (clinicaltrials.gov) - Sep 3, 2012
P=N/A, N=18, Recruiting, Sponsor: National Institute on Drug Abuse (NIDA)
- bupropion sustained-release / Generic mfg.
Trial completion: Bupropion and Weight Control for Smoking Cessation - 1 (clinicaltrials.gov) - Sep 3, 2012
P4, N=349, Completed, Sponsor: University of Pittsburgh
Not yet recruiting --> Recruiting Active, not recruiting --> Completed